Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma.

[1]  Donghui Zheng,et al.  Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195 , 2016, Oncotarget.

[2]  Qizhan Liu,et al.  The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells. , 2016, Biochimica et biophysica acta.

[3]  Xiaojuan Li,et al.  Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma , 2016, Cell Death and Disease.

[4]  F. He,et al.  Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer , 2016, Oncogene.

[5]  Gang Yang,et al.  miR-497 expression, function and clinical application in cancer , 2016, Oncotarget.

[6]  J. Rader,et al.  The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis , 2016, PloS one.

[7]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[8]  Ming Sun,et al.  Long Noncoding RNA PVT1 Promotes Non–Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression , 2016, Molecular Cancer Therapeutics.

[9]  Yao Xian,et al.  microRNA‐497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma , 2016, FEBS open bio.

[10]  Jennifer B Dennison,et al.  Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. , 2015, Cell reports.

[11]  W. Guo,et al.  MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer , 2015, Hepatology.

[12]  Baobiao Zhuo,et al.  PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. , 2015, Biochemical and biophysical research communications.

[13]  Hong Zhu,et al.  The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma , 2015, Cellular Physiology and Biochemistry.

[14]  Rui Xia,et al.  Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 , 2015, Molecular Cancer.

[15]  Mei Xue,et al.  Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR–STAT3/microRNA143 pathway , 2014, Cancer science.

[16]  L. You,et al.  MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis , 2014, Oncotarget.

[17]  P. Molloy,et al.  CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. , 2014, Biochimica et biophysica acta.

[18]  N. Seki,et al.  Tumor‐suppressive microRNA‐143/145 cluster targets hexokinase‐2 in renal cell carcinoma , 2013, Cancer science.

[19]  A. Levine,et al.  miR-143 regulates hexokinase 2 expression in cancer cells , 2013, Oncogene.

[20]  H. Tseng,et al.  MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer , 2012, Oncogene.

[21]  A. Krogh,et al.  MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells , 2012, BMC Cancer.

[22]  Yong Li,et al.  A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells , 2012, The EMBO journal.

[23]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[24]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[25]  H. Rui,et al.  Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer , 2011, Clinical Cancer Research.

[26]  Joydeep Mukherjee,et al.  Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme , 2011, The Journal of experimental medicine.

[27]  Nicholas Bertos,et al.  miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.

[28]  R. Gorlick,et al.  Osteosarcoma: a review of diagnosis, management, and treatment strategies. , 2010, Clinical advances in hematology & oncology : H&O.

[29]  J. Mendell.  MicroRNAs: Critical Regulators of Development, Cellular Physiology and Malignancy , 2005, Cell cycle.

[30]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[31]  Hui Chen,et al.  MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene. , 2016, Cancer biomarkers : section A of Disease markers.

[32]  M. Köhl,et al.  Microsoft Word-Document2 , 2003 .